![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2022
Hess, Julia; Unger, Kristian; Maihoefer, Cornelius; Schuettrumpf, Lars; Weber, Peter; Marschner, Sebastian; Wintergerst, Ludmila; Pflugradt, Ulrike; Baumeister, Philipp; Walch, Axel; Woischke, Christine; Kirchner, Thomas; Werner, Martin; Soerensen, Kristin; Baumann, Michael; Tinhofer, Ingeborg; Combs, Stephanie E.; Debus, Juergen; Schaefer, Henning; Krause, Mechthild; Linge, Annett; Gruen, Jens von der; Stuschke, Martin; Zips, Daniel; Canis, Martin; Lauber, Kirsten; Ganswindt, Ute; Henke, Michael; Zitzelsberger, Horst und Belka, Claus
(2022):
Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer Patients.
In: Cancers, Bd. 14, Nr. 15, 3745
2020
Schuettrumpf, Lars; Marschner, Sebastian; Scheu, Katrin; Hess, Julia; Rietzler, Sibylle; Walch, Axel; Baumeister, Philipp; Kirchner, Thomas; Ganswindt, Ute; Zitzelsberger, Horst; Belka, Claus und Maihoefer, Cornelius
(2020):
Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck-results from an unselected cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
In: Radiation Oncology, Bd. 15, Nr. 1, 7
2019
Hess, Julia; Unger, Kristian; Maihoefer, Cornelius; Schuettrumpf, Lars; Wintergerst, Ludmila; Heider, Theresa; Weber, Peter; Marschner, Sebastian; Braselmann, Herbert; Samaga, Daniel; Kuger, Sebastian; Pflugradt, Ulrike; Baumeister, Philipp; Walch, Axel; Woischke, Christine; Kirchner, Thomas; Werner, Martin; Werner, Kristin; Baumann, Michael; Budach, Volker; Combs, Stephanie E.; Debus, Jürgen; Grosu, Anca-Ligia; Krause, Mechthild; Linge, Annett; Roedel, Claus; Stuschke, Martin; Zips, Daniel; Zitzelsberger, Horst; Ganswindt, Ute; Henke, Michael und Belka, Claus
(2019):
A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection.
In: Clinical Cancer Research, Bd. 25, Nr. 5: S. 1505-1516